Pasture Holdings Ltd. 近日发布业绩预告，公司预计中期财务表现将受到药品批发与分销板块收入下降的拖累。这一业务部门作为集团核心收入来源之一，其营收收缩直接影响了整体盈利水平。
尽管公司未披露具体财务数据，但管理层指出，药品流通环节的市场竞争加剧及供应链成本上升是导致该板块业绩承压的主要因素。与此同时，公司其他业务板块虽保持稳定运行，但仍难以完全抵消主力业务的疲软表现。
市场分析人士认为，医药分销行业正面临结构性调整，Pasture Holdings 需通过优化供应链效率、拓展高毛利产品线等方式增强抗风险能力。公司表示将持续关注业务多元化布局，以应对行业周期性波动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.